Visterra's Grant

Visterra raised a round of funding on March 30, 2017. Investors include CARB-X.

Visterra, formerly Parasol Therapeutics, is a biotechnology company that uses its Hierotope Platform to identify unique disease targets and design effective therapeutics. The company's technology is p…

Articles about Visterra's Grant: